Nasdaq Clears Canary Capital's Injective ETF — Staking Rewards Included

Nasdaq has greenlit the listing of Canary Capital's Injective ETF, according to Cointelegraph. The fund isn't a plain vanilla crypto wrapper either — it comes with staking rewards baked in, meaning holders get exposure to both the token and the yield it generates.

That staking component is the headline. Most spot crypto ETFs approved in the U.S. so far strip out staking entirely, leaving the rewards on the table. Canary's structure keeps them in the product, which puts it in a different category from the passive trusts that came before it.

Injective is a layer-1 blockchain built for finance-focused applications. Its native token, INJ, now has a regulated vehicle queued up on a major U.S. exchange — a step that broadens who can get in on it without touching a crypto wallet.

Nasdaq's approval covers the listing itself. The news lands as issuers keep pushing the boundaries of what a crypto ETF can hold and how it can earn.

There's no word yet on a trading date or how the staking rewards will be distributed to shareholders. For now, the approval is the milestone — the plumbing comes next.